PharmaEssentia Corporation (LUX:261280558)
Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
16.80
-0.10 (-0.59%)
At close: Mar 28, 2025

PharmaEssentia Revenue

In the year 2024, PharmaEssentia had annual revenue of 9.73B TWD with 90.67% growth. PharmaEssentia had revenue of 3.06B in the quarter ending December 31, 2024, with 85.90% growth.

Revenue
9.73B TWD
Revenue Growth
+90.67%
P/S Ratio
n/a
Revenue / Employee
74.31M TWD
Employees
131
Market Cap
4.96B EUR

Revenue Chart

* This company reports financials in TWD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.73B4.63B90.67%
Dec 31, 20235.11B2.22B77.15%
Dec 31, 20222.88B2.23B339.00%
Dec 31, 2021656.51M99.25M17.81%
Dec 31, 2020557.26M251.57M82.29%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reinet Investments S.C.A. 1.04B
Luxempart 50.29M
CPI FIM 147.67M
Socfinasia 178.94M
Socfinaf 550.77M
Velcan Holdings 3.01M
GP Investments 96.12M
Revenue Rankings